EXC-31987-18973
4 vaccinations
10 coded responses
41 check-ins
10 free-text entries
7 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 381 / TN
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Pfizer-BioNTech
- 2021-04-07
-
2021-04-08
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pain — Feeling: Good · Headache, Fatigue or tirednessFree text: Sore muscle around injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
-
2021-04-29
Dose 2 — Pfizer-BioNTech
- 2021-05-05
- 2021-05-07
- 2021-05-15
- 2021-05-22
- 2021-05-27
- 2021-06-03
- 2021-06-10
- 2021-07-29
-
2021-10-28
Survey response — 6 months, dose 2MedDRA: Arthralgia, Pre-existing disease, Tendon injury — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Long term Covid respiratory Arthritis pains Strained tendon on the back of rear kneeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-29
Dose 3 — Pfizer-BioNTech
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend schoolAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-11-01
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Chest pain — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Chest painsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-05
Health check-in — day 7, dose 3Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-11-05
- 2021-11-14
- 2021-11-19
-
2021-11-28
Survey response — day 28, dose 3MedDRA: Depression, Fatigue, Headache, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Headaches, runny nose, fatigue, depressionMedDRA releases: 2024-11 · check-in free text available
-
2021-11-28
Report sent to call center — day 28, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-11-30
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-30
Call successfulParticipant prefers to complete VAERS report online
-
2021-12-03
Survey response — day 35, dose 3MedDRA: Anxiety, Balance disorder, Depression, Fatigue, Headache, Vaginal haemorrhage, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Daily headaches, vaginal bleeding, loss of balance, worsening eyesight, fatigue, anxiety, depressionMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Report sent to call center — day 35, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-07
-
2021-12-10
Survey response — day 42, dose 3MedDRA: Basal cell carcinoma — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Basal cell cancerMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-12-14
Call successfulNot applicable - Accidental Reporting
-
2021-12-14
Call successfulNot applicable - Accidental Reporting
-
2022-01-28
Survey response — 3 months, dose 3MedDRA: Asthma, Balance disorder, Cerebral disorder, Dizziness, Post-acute COVID-19 syndrome, Respiratory disorder, Syncope — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Asthma and breathing issues attributed to long Covid. Did not have these prior to 2020. Going through breathing rehab Other issues beingTreated include brain function, dizziness, loss of balance, faintingMedDRA releases: 2024-11 · check-in free text available
-
2022-01-28
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2022-01-31
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-04-07
Dose 4 — Pfizer-BioNTech
-
2022-04-18
Survey response — day 7, dose 4MedDRA: Dyspnoea — Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: Breathing difficulties - diffusion of 66%MedDRA releases: 2024-11 · check-in free text available
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
-
2022-07-08
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Got Covid again. Yes, I was fully vaccinated but got it anywsyMedDRA releases: 2024-11 · check-in free text available
-
2022-07-08
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-08
Call successfulParticipant prefers to complete VAERS report online
-
2022-10-06
Survey response — 6 months, dose 4MedDRA: Cough, Unevaluable event — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Symptoms: Deep continuous cough · Healthcare visit (other): TwiceMedDRA releases: 2024-11 · check-in free text available
-
2022-10-06
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-07
- 2022-10-11
- 2022-10-11
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-29 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
| 4 | 2022-04-07 | Pfizer-BioNTech | No |
Call center
7 call center cases
6 successful · 1 unsuccessful
VAERS report filed, before or during a call: 1
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Sore muscle around injection site
Release 10 — 6 months, dose 2
Symptoms: Long term Covid respiratory Arthritis pains Strained tendon on the back of rear knee
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Chest pains
Release 10 — day 28, dose 3
Symptoms: Headaches, runny nose, fatigue, depression
Release 10 — day 35, dose 3
Symptoms: Daily headaches, vaginal bleeding, loss of balance, worsening eyesight, fatigue, anxiety, depression
Release 10 — day 42, dose 3
Symptoms: Basal cell cancer
Release 11 — 3 months, dose 3
Symptoms: Asthma and breathing issues attributed to long Covid. Did not have these prior to 2020. Going through breathing rehab Other issues beingTreated include brain function, dizziness, loss of balance, fainting
Release 11 — day 7, dose 4
Systemic reaction (other): Breathing difficulties - diffusion of 66%
Release 12 — 3 months, dose 4
Symptoms: Got Covid again. Yes, I was fully vaccinated but got it anywsy
Release 12 — 6 months, dose 4
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Balance disorder | · | · | ✓ |
| SD | Basal cell carcinoma | · | · | ✓ |
| SD | Cerebral disorder | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Depression | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Post-acute COVID-19 syndrome | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Respiratory disorder | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Syncope | · | · | ✓ |
| SD | Tendon injury | · | · | ✓ |
| SD | Vaginal haemorrhage | · | · | ✓ |
| SD | Visual impairment | · | · | ✓ |
| SRO | Chest pain | · | · | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release